Workplace menopause policies are everywhere, but working mums still aren’t getting the treatment they need

As mandatory Menopause Action Plans approach, a prescribing pharmacist warns that awareness without clinical support risks pushing experienced women out of the workforce.

Every major employer now has a menopause policy. Awareness sessions are booked, menopause champions are appointed, and “we support our menopausal employees” sits proudly in HR handbooks.

But from last month, voluntary publication of Menopause Action Plans on the government portal has opened under the Employment Rights Act 2025, with mandatory reporting for employers of 250 or more employees following in Spring 2027. And according to Richa Puri, independent prescribing pharmacist, the corporate menopause conversation has raced ahead of the clinical one. Women are still suffering in plain sight.

“I see highly capable women in their 40s and 50s quietly stepping back from promotions, reducing their hours or leaving jobs altogether because their symptoms aren’t controlled,” says Richa. “Not because their employer doesn’t care. But because awareness without access to proper clinical management only goes so far.”

What the law requires

The legal picture is more demanding than many employers realise. Menopause isn’t itself a protected characteristic under the Equality Act 2010, but symptoms that have a long‑term, substantial impact on day‑to‑day activities can legally constitute a disability, at which point employers have a mandatory duty to make reasonable adjustments. Protection can also apply under age and sex discrimination provisions. The Health and Safety at Work Act 1974 adds a further duty of care: employers must assess whether working conditions are worsening symptoms and take reasonable steps to address them.

The new Menopause Action Plan requirements under the Employment Rights Act 2025 take this further still, expecting large employers to document evidence‑based steps covering flexible working, environmental adjustments, absence logging and access to support.

“A lunchtime awareness webinar won’t satisfy a tribunal, and it won’t satisfy your employees either,” says Richa. “Action plans need clinical grounding to mean anything.”

What’s really going on for women in the workplace

The symptoms that most affect workplace performance aren’t always the ones that most people think of. Hot flushes are well recognised, but the symptoms that cause most impact to careers are often invisible:

  • Brain fog and memory lapses affecting concentration, recall and confidence in meetings

  • Anxiety and low mood frequently misread as performance issues or personality change

  • Disrupted sleep, the downstream effects of which compound every other symptom

  • Joint pain and fatigue reducing physical stamina and tolerance for long days or commutes

  • Heavy periods, often flooding, leading to anaemia, extreme tiredness affecting performance, and embarrassment in front of colleagues

“Women tell me they’ve started writing everything down because they’re scared of forgetting things in front of colleagues,” says Richa. “That’s not a policy problem. That’s a clinical problem that needs a clinical solution.”

HRT: effective but not universal

HRT is the most effective treatment for the majority of perimenopausal symptoms, but Richa is direct about what it isn’t. “The narrative has shifted from ‘HRT is dangerous’ to ‘HRT is for everyone and should be available over the counter.’ Neither of these approaches is clinically responsible,” she says.

HRT does have contraindications. Certain types are unsuitable for women with a history of specific cancers, clotting disorders, liver disease or cardiovascular risk factors. The formulation, route of delivery and dosing matter enormously, and getting it wrong doesn’t just mean it doesn’t work; it can carry risk. A prescribing pharmacist or specialist can review the full clinical picture, including existing medication, in a way that a one‑size‑fits‑all workplace wellbeing programme simply cannot.

For women who can’t take HRT, or who are still deciding, there are evidence‑based non‑hormonal options such as certain antidepressants and holistic approaches to stress management, and these are rarely discussed in corporate wellness sessions.

What employers should and shouldn’t promise

Richa’s advice to HR directors and wellbeing leads is clear:

  • Do: create a culture where women can disclose without fear, adjust working patterns during acute symptom periods, and signpost to genuine clinical support, not just apps and helplines

  • Do: include access to a prescribing pharmacist who has been specifically trained to review HRT or a menopause specialist as part of any serious employee health benefit and build this into your Menopause Action Plan. Not all prescribing pharmacists have been trained to review HRT so make sure you ask the questions.

  • Don’t: promise that awareness training, cooling fans and flexible uniforms constitute a menopause strategy, or assume they will satisfy incoming reporting requirements

  • Don’t: conflate menopause awareness with menopause management, they are different things requiring different legal and clinical responses

“The employers getting this right are the ones treating it as an occupational health issue, not a diversity initiative,” says Richa. “That means clinical pathways, rather than a conversation, and with mandatory Action Plans on the horizon, the time frame to get ahead of this is now.”

Management in the workplace

Perimenopausal women represent one of the fastest‑growing demographics in the workforce, and untreated symptoms cost employers significantly in lost productivity, absenteeism and attrition.

However, the return on investment from menopause support depends entirely on whether that support is clinically effective.

Richa is emphatic about what a gold standard management plan could look like. She says: “Consultations would be carried out in‑house or online during working hours and would be paid for by the employer. The management would be holistic and include medication, if appropriate, as well as on‑going holistic lifestyle support. The new government plans set a great benchmark, but they need careful assessment and close attention to detail. A lunchtime webinar on ‘what is perimenopause’ isn’t going to stop a woman from resigning,” says Richa. “Helping her get her symptoms properly assessed and treated just might.”

Leave a Reply

Your email address will not be published. Required fields are marked *